Morgan Stanley Maintains Equal-Weight on Keurig Dr Pepper, Lowers Price Target to $34
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Dara Mohsenian has maintained an Equal-Weight rating on Keurig Dr Pepper (NASDAQ:KDP) but lowered the price target from $37 to $34.
February 26, 2024 | 4:03 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley maintains an Equal-Weight rating on Keurig Dr Pepper but lowers the price target from $37 to $34.
The reduction in price target by Morgan Stanley, a major financial institution, could lead to a negative short-term sentiment among investors, potentially causing a decrease in KDP's stock price. The Equal-Weight rating suggests that the analyst views the stock as fairly valued at its current price, but the lowered target indicates a reassessment of the stock's future growth potential or market conditions.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100